Already established in the liver and kidneys, radio-frequency ablation has shown early promise as a treatment for unresectable lung tumors. One of the first studies on the technique, presented by Korean researchers in May at the American Roentgen Ray Society meeting, found high mortality from the procedure but few complications among patients who responded well. In 19 patients with unresectable lung cancer ranging from stage Ib to IV, eight patients remained alive at six months of follow-up. The research team achieved complete ablation in 30% of patients, using internally cooled RF needles delivering 150 watts for 20 to 40 minutes.
Already established in the liver and kidneys, radio-frequency ablation has shown early promise as a treatment for unresectable lung tumors. One of the first studies on the technique, presented by Korean researchers in May at the American Roentgen Ray Society meeting, found high mortality from the procedure but few complications among patients who responded well. In 19 patients with unresectable lung cancer ranging from stage Ib to IV, eight patients remained alive at six months of follow-up. The research team achieved complete ablation in 30% of patients, using internally cooled RF needles delivering 150 watts for 20 to 40 minutes.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.